Home

Ogrlica Maestro Povedati resnico cell gene therapy nature biotechnology sramota Opazovanje zrezek

Gene editing for immune cell therapies | Nature Biotechnology
Gene editing for immune cell therapies | Nature Biotechnology

Gene Therapy
Gene Therapy

Engineering adeno-associated virus vectors for gene therapy | Nature  Reviews Genetics
Engineering adeno-associated virus vectors for gene therapy | Nature Reviews Genetics

Volume 15 Issue 3, September 2021
Volume 15 Issue 3, September 2021

The therapeutic landscape for cells engineered with chimeric antigen  receptors | Nature Biotechnology
The therapeutic landscape for cells engineered with chimeric antigen receptors | Nature Biotechnology

Theranostic cells: emerging clinical applications of synthetic biology |  Nature Reviews Genetics
Theranostic cells: emerging clinical applications of synthetic biology | Nature Reviews Genetics

Metabolic engineering generates a transgene-free safety switch for cell  therapy | Nature Biotechnology
Metabolic engineering generates a transgene-free safety switch for cell therapy | Nature Biotechnology

A computationally designed chimeric antigen receptor provides a  small-molecule safety switch for T-cell therapy | Nature Biotechnology
A computationally designed chimeric antigen receptor provides a small-molecule safety switch for T-cell therapy | Nature Biotechnology

Patient and public perspectives on cell and gene therapies: a systematic  review | Nature Communications
Patient and public perspectives on cell and gene therapies: a systematic review | Nature Communications

Viral vector platforms within the gene therapy landscape | Signal  Transduction and Targeted Therapy
Viral vector platforms within the gene therapy landscape | Signal Transduction and Targeted Therapy

Non-viral vectors for gene-based therapy | Nature Reviews Genetics
Non-viral vectors for gene-based therapy | Nature Reviews Genetics

Gene therapy avenues and COVID-19 vaccines | Genes & Immunity
Gene therapy avenues and COVID-19 vaccines | Genes & Immunity

The transformative potential of HSC gene therapy as a genetic medicine | Gene  Therapy
The transformative potential of HSC gene therapy as a genetic medicine | Gene Therapy

Realizing the promise of gene therapy through collaboration and partnering:  Pfizer's view
Realizing the promise of gene therapy through collaboration and partnering: Pfizer's view

The delivery challenge: fulfilling the promise of therapeutic genome  editing | Nature Biotechnology
The delivery challenge: fulfilling the promise of therapeutic genome editing | Nature Biotechnology

Next-generation stem cells — ushering in a new era of cell-based therapies  | Nature Reviews Drug Discovery
Next-generation stem cells — ushering in a new era of cell-based therapies | Nature Reviews Drug Discovery

Gene therapy for ALS: A review: Molecular Therapy
Gene therapy for ALS: A review: Molecular Therapy

Overcoming cellular barriers for RNA therapeutics | Nature Biotechnology
Overcoming cellular barriers for RNA therapeutics | Nature Biotechnology

Disruptions in the development of cell and gene therapies
Disruptions in the development of cell and gene therapies

Design of efficacious somatic cell genome editing strategies for recessive  and polygenic diseases | Nature Communications
Design of efficacious somatic cell genome editing strategies for recessive and polygenic diseases | Nature Communications

Next-generation therapeutics: cell and gene therapy gathers pace
Next-generation therapeutics: cell and gene therapy gathers pace

Gene therapy is facing its biggest challenge yet
Gene therapy is facing its biggest challenge yet

Current status and perspective of CAR-T and CAR-NK cell therapy trials in  Germany | Gene Therapy
Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany | Gene Therapy

Gene Therapy | Learn Science at Scitable
Gene Therapy | Learn Science at Scitable

CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared  by virus-free Sleeping Beauty gene transfer to treat multiple myeloma | Gene  Therapy
CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma | Gene Therapy